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Relationship between selected hormonal and metabolic parameters at
birth and blood pressure during pre-adolescence
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ABSTRACT
Objective: The aim of the present study was to evaluate the relationship between selected hormonal parameters (at birth
and at age 8 years) and blood pressure levels at pre-adolescence in a cohort of intrauterine growth retarded (IUGR) and normal
birth weight infants (NBW).
Methods: A cohort study from early pregnancy to childhood was performed. Seventy-six fetuses/children were evaluated
between 1995 and 2004. Cord blood samples were taken at birth and several hormonal and metabolic parameters evaluated.
Sixty-four children of the original cohort were available for blood sampling, blood pressure and anthropometric measures at
a mean age of 8 years. 27 (42.2%) were IUGR and 37 (57.8%) were NBW. Multiple regression analyses were conducted with
cord blood levels of hormonal and metabolic parameters at birth and at 8 years as independent variables and children’s blood
pressure as dependent variable adjusted by IUGR status, gender, Body Mass Index and age of the child at the time of blood
pressure evaluation.
Results: The maternal age (26.6±5.8 vs 26.9±5.8 years old) and the gestational age at birth (39.1±1.4 vs 39.6±1.3 weeks) were
similar between the groups. IUGR children were shorter (1.28± 0.09 m vs 1.33± 0.09 m, p=0.04). Growth hormone levels (GH)
at birth were negatively associated with systolic blood pressure at 8 years of age (regression coefficients for umbilical cord
blood levels: -0.9, 95% CI -2.03 to 0.04 mg/ml, p= 0.04).
Conclusion: The alterations on blood pressure can begin in fetal life were levels of GH could have an important role.
Keywords: Restriction of intrauterine growth; Fetal growth hormone; Pre-adolescence growth; Blood pressure.
Relación entre parámetros endocrino-metabólicos al nacimiento y la presión arterial durante la pre-adolescencia
RESUMEN
Objetivo: Evaluar la relación entre parámetros hormonales seleccionados (al nacimiento y a los 8 años de edad) y los niveles
de presión arterial a los 8 años de edad en una cohorte de niños con restricción en el crecimiento intrauterino (RCIU) y con
peso normal al nacimiento (PNN).
Material y métodos: Se realizó un estudio de cohortes desde el inicio del embarazo hasta la infancia (1995-2004). Se tomaron
muestras de sangre de cordón umbilical al nacimiento y a los 8 años para evaluar parámetros endocrino-metabólicos
seleccionados (variable independiente) y la presión arterial a los 8 años de edad (variable dependiente). Se evaluaron 64 niños
de la cohorte original; 27 (42.2%) casos pertenecían al grupo de RCIU y 37 (57.8%) al grupo con PNN. El análisis multivariado
se ajustó por RCIU, género, índice de masa corporal y edad del niño en el momento de medir la presión arterial.
Resultados: La edad de las madres (26.6±5.8 vs 26.9±5.8 años) y la edad gestacional al parto (39.1±1.4 vs 39.6±1.3 semanas)
fueron similares entre los grupos. Los niños de 8 años que nacieron con RCIU fueron más bajos (1.28± 0.09 m vs 1.33± 0.09
m, p=0.04). Los niveles de hormona de crecimiento (GH) al nacimiento fueron asociados negativamente con la presión arterial
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sistólica del niño (coeficiente de regresión: -0.9, 95% CI -2.03
a 0.04 mg/ml, p=0.04).
Conclusión: Las alteraciones de la presión arterial pueden
comenzar desde la vida fetal y los niveles de GH fetal pueden
jugar un papel importante.
Palabras clave: Restricción de crecimiento intrauterino;
Niveles hormonales fetales; Crecimiento en la
preadolescencia; Presión arterial.
The possibility of an intrauterine programming of
blood pressure later on in life and the risk of various
chronic diseases attracts considerable interest. This
hypothesis is supported by a growing number of
observational and experimental studies1 although
concerns have been raised on some methodological
limitations of these studies, the different outcomes
selected and the inconsistencies of the results2.
Furthermore, most studies used birth weight and other
anthropometric measures at birth as proxy indicators for
intrauterine growth impairment without providing
physiological or metabolic explanatory data for the
possible mechanisms underlining these associations. It
was observed3 endocrinological alterations associated
with intrauterine growth restriction, particularly higher
growth hormone values in cord blood at birth, perhaps as
a functional compensatory mechanism of the
hypothalamic-pituitary axis to foetal growth restriction3.
As a follow-up to these results, we have conducted the
present prospective study specifically designed to
evaluate the following «a-priori» question: is there a
relationship between selected hormonal and metabolic
parameters at birth and at 8 years of age with blood
pressure during pre-adolescence? Also, we have
evaluated the differences in postnatal growth and blood
pressure between intrauterine growth restriction (IUGR)
and normal birth weight (NBW) children.
MATERIAL AND METHODS
Original cohort. This is a follow-up pilot study of a
cohort of infants born between 1995 and 2004 at the
Department of Obstetrics and Gynaecology, Principe
de Asturias University Hospital, Alcalá de Henares,
Madrid, Spain. The original population included 94
singleton pregnancies, without congenital malformations
and/or chromosomal abnormalities that delivered at
term (>37 weeks to <42 weeks of gestation). This study
was specifically conducted to explore the association
between newborn anthropometric and endocrine
parameters, the present follow-up represents a natural
extension of this initial research3. Gestational age was
calculated using the date of the last menstrual period and
first trimester ultrasound measures and corroborated by
physical examination of the newborn. In case of
disagreement of more than two weeks among the
different methods, early ultrasound dating was used.
There were 47 fetus suspected at ultrasound examination
to have intrauterine growth restriction (IUGR), of whom
31 actually had birth weight at or below the tenth
percentile of a local standard confirming the diagnosis3
they constitute the IUGR population. Forty-seven
newborns were identified immediately after birth of
each suspected IUGR and selected as controls, if they
had birth weight >10th percentile of the same local
standard3; they are the normal birth weight population.
There were two eligible control newborns that could not
be included because cord blood collection was not
possible. Therefore the initial study population includes
31 confirmed IUGR and 45 NBW infants3.
Follow-up. Between 1 November 2003 and 30
September 2004 (on average 8 years postpartum) all the
76 families of the newborns originally studied were
identified from hospital records and contacts were
attempted to their last known address; those that could
not be located were contacted using the social security
number registered in the medical record and the new
address reported to the regional health care authority.
One IUGR child died at one year of age of meningitis
and 3 IUGR and 8 NBW refused to participate. Thus,
we were able to locate 64 children from the original
cohort (84%) and assessed during childhood 27 IUGRs
(87%) and 37 NBW infants (82%).
Blood extractions, physical examinations and a brief
pediatric history were conducted at the hospital between
8 and 9 am. Height was measured using custom-made
stadiometers with the children wearing no shoes. Weight
was measured using calibrated scale with children in
light clothing. Skinfold measurement was obtained at the
triceps and subscapular sites with «Holtain caliper,
UK». All anthropometric measurements were taken
twice. Body Mass Index (BMI) was calculated as
weight in kilograms divided by the square of height in
meters. Examinations of the children were conducted at
a mean age of 8.0 (SD 1.1) years in the IUGR group and
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8.4 (SD 1.0) years in the normal birth weight group.
Systolic and diastolic blood pressure were measured
in the child’s right arm, after a period of rest, in a seated
position with the arm resting on a supportive surface at
the heart level, by only one examiner, a nurse-midwife
specifically trained for this study. She was blinded to the
birth characteristics of the children and to the specific
hypotheses of the study. Two consecutive measures of
systolic and diastolic blood pressure (Korotkoff  V
sound; disappearance of sounds) were taken five minutes
apart using a standard mercury sphygmomanometer
with a cuff bladder size of 15 cm by 9 cm following the
recommended criteria4. The average of the two blood
pressure recordings was considered as the blood pressure
for the analyses.
IUGR and NBW children were compared at a mean
age of 8 years using standard statistical methods for
mean and proportions. Multiple linear regression analyses
were conducted using as dependent variable blood
pressure during childhood and, as independent variables,
the hormonal and metabolic values measured in cord
blood and blood samples at assessment. Adjustments
were made by gender, fetal growth category (IUGR
versus NBW), gestational age at birth, maternal smo-
king and educational level, as well as children’s age and
body mass index (BMI) at assessment, as possible
confounding variables. We used the Statview II statistical
package in all analyses.
This study was approved following the routine review
process of the Department of Obstetrics and Gynae-
cology of the Principe de Asturias University Hospital,
Alcalá de Henares, Madrid, Spain and the Institutional
Ethical Committee. Mothers provided informed consent
for the blood pressure measurements and blood
extractions of their children.
Laboratory methods. Arterial blood umbilical cord
samples were taken immediately after birth, at umbilical
cord clamping but before cutting the cord. Each sample
of 20 ml was processed in duplicate, centrifuged and
stored at -40°C until assay. At age 8 years, fasting blood
samples were collected by venoclisis of the cubital vein.
15 ml of blood were extracted and processed in the same
as the umbilical cord blood samples, the same serum
parameters as at birth were determined. The laboratory
team was blind to clinical condition of the patient.
We measured in these samples selected hormonal
and metabolic parameters as growth hormone (GH),
insulin growth factor-I (IGF-I), cortisol, insulin, tiro-
stimuline hormone (TSH), prolactin, glucose, cholesterol,
triglycerides, albumin and magnesium. We did not
measure IGF-I binding protein independently. IGF-I
was measured by radio immunoassay (Lab. Systems,
USA), insulin and GH by colorimetric enzymo-
immunoassay (Medgenix Diagnostics, Belgium)5. For
insulin intra-assay coefficient of variation of 3.6%,
inter-assay coefficient of variation of 7.1% for GH;
TSH by fluorometric assay (Baxter S.A., USA)6; cortisol
by fluorescence polarization immunofluorometric assay
(Abbott SA, USA), intra-assay coefficient of variation
of 4.1%, inter-assay coefficient of variation of 7.2%;
prolactin by a immunofluorometric assay (Pharmacia
LKB-Wallac, Finland), intra-assay coefficient of variation
of 3.3%, inter-assay coefficient of variation of 4%. The
metabolic parameters (insulin and cholesterol levels)
were measured with the Hitachi 717 autoanalyzer,
Tokyo, Japan. A significant statistical difference was
considered with a p value lower than 0.05.
RESULTS
The maternal age was similar between the groups
(Table 1). The weeks of gestational age at birth and the
height of the newborns were similar between the groups
(Table 1). The mean of the birthweight and the neonatal
ponderal index was different between the groups (Table
1). Tables 2 and 3 show data for hormonal and metabolic
parameters at birth and at 8 years of age for the children
included classified as intrauterine growth restriction
(IUGR) and normal birth weight (NBW). At birth IUGR
children had higher cord blood growth hormone levels
but lower insulin, thyroid stimulating hormone and
cholesterol values (Table 2). IGF-I intra-assay coeffi-
cient of variation of 4.2%, inter-assay coefficient of
variation of 5.1%. We found no statistical significant
differences between groups of these parameters at age
of 8 years although growth hormone levels remained
higher in the IUGR group (Table 3).
At 8 years of age IUGR children were shorter,
tended to be lighter but had similar BMI than the NBW
group (Table 4). At this age, the mean systolic and
diastolic blood pressure in the IUGR group was lower as
compared with the NBW group without statistical
difference. IUGR children have mean systolic and
diastolic blood pressure 3.64 mmHg and 2.63 mmHg
12
Colombia Médica                 Vol. 40 Nº 1, 2009 (Enero-Marzo)
Table 1
Perinatal characteristics at birth of 64 children.
Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain. 1995
Intrauterine growth restriction   Normal birth weight             p
(N= 27)              (N=37)
  Gestation age (wk.) (Mean/SD) 39.1±1.4 39.6±1.3 0.09
  Maternal age (years) (Mean/SD)  26.6±5.8 26.9±5.8 0.62
  Weight (at birth (g) (Mean/SD) 2487±221 3269±345 < 0.01
  Height (at birth) (cm) (Mean/SD)  48.09±2.31 48.15±2.16 0.87
  Neonatal ponderal index  2.44±0.33 2.70±0.23 <0.01
respectively lower than NBW children (PNS) after
adjusting by Body Mass Index, gender and age at
assessment.
At 8 years of age, in the crude analysis, for the
complete population, there was an overall positive
relationship between BMI (kg/m2) and systolic
(beta=1.15; 95% confidence interval 0.33 to 1.96 (mmHg)
(p=0.006)) and diastolic blood pressure (beta=1.16;
95% confidence interval 0.55 to 1.77 (mmHg) (p=0.003).
Table 5 presents the multiple linear regression analysis
between hormonal and metabolic parameters in cord
blood at birth and at 8 years of age as independent
variables, and blood pressure at 8 years of age as the
dependent variable. Results presented are adjusted by
gender, gestational age at birth, age and body mass
index of the child at the time of blood pressure mea-
surement as well as for the other variables in the
regression model, including intrauterine growth category
(IUGR vs. NBW).
Independent of the other variables considered, growth
hormone at birth and at age 8 years were negatively
associated with systolic blood pressure at age 8 years.
There is the same tendency with diastolic blood pressure.
Adding to this regression model TSH, insulin, prolactin,
cholesterol, glucose, albumin and magnesium did not
change the observed results (Table 5). The mothers’
educational level, used as a proxy indicator for
* Mean (standard error)
Intrauterine growth restriction   Normal birth weight             p
(N= 27)              (N=37)
25.8 (3.3) 15.7 (1.5) 0.0008
0.6 (0.09) 0.7 (0.06) 0.3
15.9 (1.9) 17.6 (1.8) 0.2
2.5 (0.6) 5.2 (0.9) 0.05
9.2 (0.8) 14.3 (1.7) 0.03
226.9 (12.4) 208.2 (12.3) 0.2
86.0 (5.1) 96.0 (3.9) 0.13
60.5 (2.2) 70.3 (2.6) 0.01
35.6 (2.8) 37.3 (1.9) 0.29
3.9 (0.05) 4.2 (0.04) 0.009
5.9 (0.1) 6.0 (0.08) 0.5
1.9 (0.05) 1.8 (0.02) 0.01
Table 2
Hormonal and metabolic characteristics at birth of 64 children.
Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain. 1995
             Parameter
  Growth hormone (ng/ml)
  Insulin-like growth factor I (mU/ml)
  Cortisol (ug/dI)
  Insulin (U/ml)
  Thyroid stimulating hormone(uU/ml)
  Prolactin (ng/mI)
  Glucose (mg/dl)
  Cholesterol (mg/dl)
  Triglycerides (mg/dl)
  Albumin (g/dl)
  Total protein
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socioeconomic status, did not modify these relationships
either.
DISCUSSION
We have prospectively studied a cohort, from
pregnancy to childhood, with a priori defined objectives,
using biochemical indicators of fetal growth and nutritional
status specifically collected for this study. As was
expected the perinatal characteristics of the newborns
were according with the clinical status of the groups
(Table 1) and the body mass index was correlated with
both systolic and diastolic blood pressure (p=0.003).
The diagnosis of IUGR was made by both ultrasound
examinations during pregnancy and birthweight. The
small sample size of the original population, as well as
that of the follow-up cohort, is a limitation but the
response rate of  84% is very adequate within the
expected rate for follow-up studies in children and
adolescents7. Although we followed presently
recommended techniques for systolic and diastolic
blood pressure measurement in children4, the single
measurement of blood pressure is also a limitation
because longitudinal blood pressure recordings better
Table 3
Hormonal and metabolic characteristics at age 8 years of 64 children.
Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain. 2004
   Parameter Intrauterine growth restriction   Normal birth weight             p
(N= 27)              (N=37)
Growth hormone (ng/ml) 1.2 (0.6)* 0.9 (0.4) 0.6
Insulin-like growth factor I (ng/ml) 184.1 (16.3) 196.6 (17.7) 0.6
Cortisol (ug/dI) 16.5 (1.2) 14.7 (1.4) 0.3
Insulin (U/Mi) 13.2 (2.5) 11.7 (1.9) 0.6
Thyroid stimulating hormone(U/ml) 2.9 (0.2) 2.8 (0.2) 0.8
Prolactin (ng/mI) 7.4 (0.6) 10.9 (2.2) 0.1
Glucose (mg/dl) 85.3 (1.5) 88.6 (1.5) 0.1
Cholesterol (mg/dI) 169.6 (5.6) 168.3 (6.7) 0.8
Triglycerides (mg/dl) 73.8 (9.2) 75.8 (9.2) 0.8
Total protein (g/dI) 7.4 (0.07) 7.3 (0.08) 0.4
Magnesium (mg/dI) 1.9 (0.06) 1.7 (0.09) 0.1
 * Mean (standard error)
Table 4
Clinical characteristics at age 8 years of 64 children.
Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain. 2004
Parameter Intrauterine growth restriction   Normal birth weight             p
(N= 27)              (N=37)
  Age (years) 8.0 (1.05)* 8.4 (1.04) 0.2
  Weight (kg) 28.2 (6.67) 31.7 (9.75) 0.1
  Height (cm) 128.9 133.9 0.04
  Body mass index (kg/m2) 17.1 (3.13) 17.6 (3.28) 0.5
  Systolic blood pressure (mmHg) 87.2 (11.95) 90.9 (10.04) 0.1
  Diastolic blood pressure (mmHg) 53.5 (6.12) 56.1 (9.94) 0.2
  * Mean (standard deviation)
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represent the true blood pressure level of a child.
Unfortunately, placental weight was not available, limiting
the possibility of exploring the fetal-placental ratio/blood
pressure relationship.
This study presents evidence that serum growth
hormone (GH) at birth and at 8 years were negatively
associated with systolic blood pressure during childhood
independently of the gestational age, gender, age, IUGR/
NBW status, and BMI at the time of blood pressure
assessment. This evidence supports the suggestion8 that
the fetal activation of the hypothalamic-pituitary axis
and its long-term effect is related to the programming of
cardiovascular development and blood pressure during
childhood.
Disturbances in the GH/insulin-like growth factor I
axis are recognized as related to post natal growth
failure among IUGR infants9 and their influence during
growth hormone treatment among IUGR infants10.
However, these disturbances are not always consistent
in the literature, perhaps due to the molecular
heterogeneity of GH and levels of bioinactive but
immunologically active GH molecules.
There are several reports documenting lower mean
estimated secretion rates of GH in prepubertal short
children born IUGR11, while others failed to demonstrate
differences in urinary GH by patterns of catch-up
growth among IUGR infants12. Furthermore, the
relationship between GH and IGF-I is also influenced by
race and gender13. An increased proportion of circulating
non-22-kilodalton GH is reported in short children14
while children 2 to 5 years born IUGR were found to
have high basal GH levels11. Finally, a non statistical
significant negative relationship was observed between
urinary GH and blood pressure at 9 years of age15. It is
important to point out that all this evidence is related to
hormonal values during childhood, while our paper
presents data on hormonal values at birth and at the time
of blood pressure measure before puberty.
The mechanisms responsible for the negative
association between growth hormone at birth and blood
pressure during childhood are unclear at this point. The
growth hormone increase among IUGR infants can be
seen as a response to foetal growth alterations most
likely unrelated to IGF-I. In this regard, the observed
Table 5
Multiple regression analysis of the association between biochemical indicators and blood pressure.
Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
    Independent variable           Systolic blood pressure      Diastolic blood pressure
At birth Regression coefficients Regression coefficients
Growth hormone (ng/ml) -0.143* (-0.356 to 0.069) -0.078 (-0.244 to 0.088)
IGF1 (mU/ml) -0.401 (-8.375 to 7.573) 2.598 (-3.642 to 8.838)
Cortisol (ug/dl) 0.145 (-0.164 to 0.455) 0.137 (-0.105 to 0.379)
Insulin (uU/ml) -0.041 (-0.682 to 0.6) -0.133 (-0.635 to 0.369)
TSH (uU/ml) 0.055 (-0.19 to 0.301) -0.071 (-0.264 to 0.121)
Prolactin (ng/ml) 0.005 (-0.036 to 0.046) -0.0004 (-0.032 to 0.033)
At 8 years of age
Growth hormone (ng/ml) -1.076 (-2.271 to 0.12) -0.488 (-1.423 to 0.448)
IGF1 (ng/ml) -0.013 (-0.051 to 0.025) -0.029+ (-0.059 to 0.001)
Cortisol (ug/dl) 0.09 (0.322 to 0.502) 0.088 (-0.234 to 0.411)
Insulin (uU/ml) 0.148 (-0.124 to 0.421) 0.096 (-0.116 to 0.309)
TSH (uU/ml) 1.863 (-1.023 to 4.479) -0.777 (-1.482 to 3.036)
Prolactin (ng/ml) -0.186 (-0.501 to 0.13) -0.276+ (-0.523 to -0.029)
There were 27 intrauterine growth restricted and 37 normal birth weight newborns/children pairs. All regression coefficients were
adjusted by gender, gestational age at birth, BMI at 8 years and IUGR/NBW category
* Regression coefficients and 95% confidence interval in mmHg. + p=0.05
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negative association between growth hormone and
blood pressure at age 8 could be seen as a chronic
adaptation to a growth deficit becoming a risk factor for
adult diseases particularly among short children.
Interestingly, the higher GH levels at birth among IUGR
children are not sufficient for a growth catch-up during
childhood.Furthermore, our results provide empirical
support for the suggestion that blood pressure and
somatic growth in children are governed by the similar
process16 which, as we have shown, is initiated during
fetal life, and is still present during childhood1.
This process would involve hormones with known
growth activity in uterus, such as IGF-I17 or ACTH with
effect on blood pressure increase18. It is possible that
intrauterine hormonal, nutritional or organ growth altera-
tions can stimulate in uterus, the growth hormone -IGF-
I axis predisposing some newborns to higher blood
pressure when confronted with rapid growth during
childhood. This could be the case of a subgroup of
IUGR infants with higher levels of growth hormone at
birth3 or those with high response to growth hormone-
releasing hormone19. It is clear that the development of
the cardiovascular system (antenatal and postnatal) as
well as the regulation of blood pressure up to adulthood
is controlled by several interrelated mechanisms20. The
evidence presented here represents one of such
mechanisms complementing others, nutritional or
environmental, which are yet to be disentangled. We
conclude that the alterations on blood pressure can
begin in fetal life were levels of GH could have an
important role.
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